Pharmaceutical Business Confidence Report Q4 2014

“• Overall, 46% of pharmaceutical industry respondents state that they are operating in a stable economic environment, while 42% state that their current economic conditions are favorable
• The majority of global pharmaceutical industry respondents anticipate positive growth for both their companies and the industry over October–December 2014
• Industry respondents from Asia-Pacific expect the highest growth in staff headcount and sales volume in October–December 2014
• Improving operational efficiency and protecting and growing market share are the most popular priorities by pharmaceutical industry executives operating across all regions
• Highest percentage, 79%, of the survey respondents operating in Europe gives high preference for outright purchase in Q4 2014, while 21% of the respondents show less preference
• Respondents intend to allocate the biggest part of their procurement budget towards meeting operating expenses in 2015
• Survey results indicated that 35% of the survey respondents invest on the laboratory instrument every year.”

“Methodology and sample size
• Confidence indexes
• State of the economy
• Growth prospects and customer confidence
• Supplier prices and levels of expenditure
• Organizational outlook and strategy
• Procurement budget and expenditure outlook
• Appendix”